The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia.
To clarify the extent of cell lineage involvement in chronic myelogenous leukemia (CML), we investigated the bcr gene rearrangement and clonality using the X-chromosome-linked restriction fragment length polymorphism (RFLP) methylation method in T lymphocytes and granulocytes. We examined the granulocyte and T-cell fractions from the peripheral blood of seven female patients with CML during the chronic phase; patients were heterozygous for RFLPs at the phosphoglycerate kinase (PGK) or the hypoxanthine phosphoribosyltransferase (HPRT) gene. RFLP-methylation analysis of granulocytes demonstrated a monoclonal pattern in six of the seven patients and a rearranged bcr gene in all seven patients. In contrast, T lymphocytes exhibited a polyclonal pattern in six cases; in one case, a faint band was observed following methyl-sensitive enzyme cleavage. The bcr gene analysis in T lymphocytes showed the germline in every case. Our results indicate that the majority of T lymphocytes are polyclonal during the chronic phase of CML and confirm previous reports based on glucose-6-phosphate dehydrogenase, cytogenetic, and bcr rearrangement analyses.
Tsukamoto
N
N
Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan.
Karasawa
M
M
Maehara
T
T
Okamoto
K
K
Sakai
H
H
Naruse
T
T
Morita
K
K
Tsuchiya
J
J
Omine
M
M
D000328:Adult; D014408:Biomarkers, Tumor / Q000032:analysis / Q000235:genetics; D002999:Clone Cells / Q000473:pathology*; D005260:Female; D016044:Fusion Proteins, bcr-abl / Q000032:analysis / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000032:analysis / Q000235:genetics; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics / Q000276:immunology / Q000473:pathology*; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis / Q000235:genetics; D010735:Phosphoglycerate Kinase / Q000032:analysis / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D016176:T-Lymphocyte Subsets / Q000473:pathology*
D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D007041:Hypoxanthine Phosphoribosyltransferase; D016044:Fusion Proteins, bcr-abl; D010735:Phosphoglycerate Kinase